sanofi: Sanofi trial failure ends development of breast cancer treatment amcenestrant
French healthcare company Sanofi said it would stop further work on amcenestrant, once seen to have large potential against breast cancer, after a second trial failure dealt a major blow to its drug development prospects.
The move puts…